Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen
Completed · Phase 3
Conditions studied: Hemophilia A, Hemophilia B
In brief
The purpose of the study is to determine the efficacy and safety of rFVIIa BI as part of a six-month on-demand treatment regimen in hemophilia A or B subjects with inhibitors.
Key facts
- Study ID
- NCT01757405
- Run by
- Baxalta now part of Shire
- People needed
- 40
- Starts
- 2013-02-20
- Expected to finish
- 2014-11-11
- Last updated by the study team
- 2021-05-11
Who can join
Age: 12 and older, up to 65. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Health Point Medical Group "St Joseph's Children's Hospital" — Tampa, Florida, United States
- Nara Medical University Hospital — Nara, Japan
- Tokyo Medical University Hospital — Tokyo, Japan
- Kracow Medical Center, LLC — Krakow, Poland
- Institute of Haematology and Transfusion Medicine, Clinic of Haemostatic Disorders and Internal Diseases — Warsaw, Poland
- Louis Turcanu Emergency Clinical Children´s Hospital — Timișoara, Romania
- Kirov Hematology and Blood Transfusion Research Institute under the Federal Medical and Biological Agency of Russia — Kirov, Russia
- Hematology Research Center under RAMS (State Institution), Department of Reconstructive Orthopedic Surgery for Hemophilia Patients — Moscow, Russia
- St. Petersburg City Healthcare Institution Municipal Policlinic # 37 — Saint Petersburg, Russia
- Clinic for Hematology of the Clinical Center of Serbia — Belgrade, Serbia
- Hospital Teresa Herrera Materno Infantil del C.H.U.Carretera del Pasajes/nlaboratorio de hematología — A Coruña, Spain
- University Hospital Virgen del Rocio — Seville, Spain
- Tri-Service General Hospital (TSGH) — Taipei, Taiwan
- V.K. Gusak Institute of Urgent and Reconstructive Surgery within the Ukrainian National Academy of Medical Sciences, Hematology Department — Donetsk, Ukraine
- Kyiv City Clinical Hospital #9, City Scientific-Practical Center for Diagnostics and Treatment of Patients with Hemostatic Pathlogies — Kiev, Ukraine
- State Institution "Institute of Blood Pathology and Transfusion Medicine within the Ukrainian National Academy of Medical Sciences", Hematology Department — Lviv, Ukraine
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.